EP3326616
LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.6.2012:
28.7.2021:
17202117.2
:
2.6.2032
:
LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT
3.6.2012
28.7.2021
:
Signpath Pharma Inc.:
9710 Ruskin Circle, Sandy, UT 84092, US
:
HELSON, Lawrence:
Quakertown, PA Pennsylvania 18951, US
:
201161493257 P:
3.6.2011:
US
:
A61K 9/127, A61P 9/00, A61P 9/04, A61K 31/12, A61K 31/445, A61K 31/18